Proprietary AI analyst is now available

UV Germi Valuation Multiples

Discover revenue and EBITDA valuation multiples for UV Germi and similar public comparables like Geotrans, Telesto, Decent Holding, Ambipar Emergency and more.

UV Germi Overview

About UV Germi

UV Germi SA develops and manufactures UV sterilizers for water treatment.


Founded

1979

HQ

France

Employees

46

Website

uvgermi.fr

Financials (FY)

Revenue: $8M
EBITDA: $505K

EV

$1M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

UV Germi Financials

UV Germi reported last fiscal year revenue of $8M and EBITDA of $505K.

In the same fiscal year, UV Germi generated $4M in gross profit, $505K in EBITDA, and $118K in net income.

Revenue (LTM)


UV Germi P&L

In the most recent fiscal year, UV Germi reported revenue of $8M and EBITDA of $505K.

UV Germi is profitable as of last fiscal year, with gross margin of 46%, EBITDA margin of 6%, and net margin of 1%.

See analyst estimates for UV Germi
Last FY202320242025202620272028
Revenue$8M$9M$10M$8M
Gross Profit$4M$4M$5M$4M
Gross Margin46%45%47%46%
EBITDA$505K$718K$1M$505K
EBITDA Margin6%8%11%6%
EBIT Margin1%7%7%1%
Net Profit$118K$337K$824K$118K
Net Margin1%4%8%1%

Financial data powered by Morningstar, Inc.

UV Germi Stock Performance

UV Germi has current market cap of $7M, and enterprise value of $1M.

Market Cap Evolution


UV Germi's stock price is $2.73.

UV Germi share price decreased by 2.9% in the last 30 days, and by 7.3% in the last year.

UV Germi has an EPS (earnings per share) of $0.05.

See more trading valuation data for UV Germi
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1M$7M0.5%-2.9%4.1%-7.3%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

UV Germi Valuation Multiples

UV Germi trades at 0.2x EV/Revenue multiple, and 2.4x EV/EBITDA.

See NTM and 2027E valuation multiples for UV Germi

EV / Revenue (LTM)


UV Germi Financial Valuation Multiples

As of June 6, 2026, UV Germi has market cap of $7M and EV of $1M.

UV Germi has a P/E ratio of 55.8x.

Last FY202320242025202620272028
EV/Revenue0.2x0.1x0.1x0.2x
EV/EBITDA2.4x1.7x1.2x2.4x
EV/EBIT11.6x1.9x1.7x11.6x
EV/Gross Profit0.3x0.3x0.3x0.3x
P/E55.8x19.5x8.0x55.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified UV Germi Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

UV Germi Margins & Growth Rates

In the most recent fiscal year, UV Germi reported gross margin of 46%, EBITDA margin of 6%, and net margin of 1%.

See estimated margins and future growth rates for UV Germi

UV Germi Margins

Last FY20242025202720282029
Gross Margin46%47%46%
EBITDA Margin6%11%6%
EBIT Margin1%7%1%
Net Margin1%8%1%

UV Germi Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth6%(20%)
Gross Profit Growth11%(23%)
EBITDA Growth47%(52%)
EBIT Growth10%(85%)
Net Profit Growth145%(86%)

Data powered by FactSet, Inc. and Morningstar, Inc.

UV Germi Operational KPIs

UV Germi's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for UV Germi
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.1M---
Opex to Revenue44%38%40%44%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Geotrans1.1x-9.4x-
Telesto2.8x-35.8x-
Decent Holding0.5x-(191.9x)-
Ambipar Emergency----
Gomero Group0.7x-9.4x-
WF International0.4x-(2.1x)-
LiqTech International1.2x1.0x(3.2x)-
Aker Carbon Capture(298.7x)-(199.1x)-

This data is available for Pro users. Sign up to see all UV Germi competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About UV Germi

When was UV Germi founded?UV Germi was founded in 1979.
Where is UV Germi headquartered?UV Germi is headquartered in France.
How many employees does UV Germi have?As of today, UV Germi has over 46 employees.
Is UV Germi publicly listed?Yes, UV Germi is a public company listed on Euronext Paris.
What is the stock symbol of UV Germi?UV Germi trades under ALUVI ticker.
When did UV Germi go public?UV Germi went public in 2017.
Who are competitors of UV Germi?UV Germi main competitors include Geotrans, Telesto, Decent Holding, Ambipar Emergency, Gomero Group, WF International, LiqTech International, Aker Carbon Capture, WasteCo Group, Axolot Solutions Holding.
What is the current market cap of UV Germi?UV Germi's current market cap is $7M.
What is the current revenue of UV Germi?UV Germi's last fiscal year revenue is $8M.
What is the current EV/Revenue multiple of UV Germi?Current revenue multiple of UV Germi is 0.2x.
Is UV Germi profitable?No, UV Germi is not profitable.
How many companies UV Germi has acquired to date?UV Germi hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies UV Germi has invested to date?UV Germi hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to UV Germi

Lists including UV Germi

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial